S., Abbas, H., Zewail, M., Noureldin, M
Following single administration, the elimination half-life of prototype BPC-157 was less than 30 minutes in both species, indicating rapid systemic clearance
[42] At the GLP-1 receptor, though, tirzepatide shows bias toward cAMP (a messenger associated with regulation of glycogen, sugar, and lipid metabolism) generation rather than -arrestin recruitment
En un subestudio del ensayo de fase 3 SURPASS-3, en pacientes con DM2 y esteatosis heptica, tirzepatida, tras 52 semanas de tratamiento en dosis de 10mg y 15mg, redujo significativamente el contenido de grasa heptica con una diferencia estimada de 4,71% frente a insulina degludec24